Rainer Oberbauer – Nephrology Laboratory

87. Polygenic risk scores in kidney transplantation. Curr Opin Organ Transplant. 2025 (in press)

Jelencsics K, Oberbauer R.

86. [Nomenclature for kidney function and kidney diseases – Improving assessment and prognosis through precision and comprehensibility]. Dtsch Med Wochenschr. 2022, 147(21):1398-1406 View PDF

Eckardt KU, Binet I, de Groot K, Floege J, Galle JC, Jordans I, Kribben A, Oberbauer R, Pavenstädt H, Rosenkranz A, Säemann M, Winkelmayer WC

85. Lessons from effect of etelcalcetide on left ventricular hypertrophy in patients with end-stage kidney disease. Curr Opin Nephrol Hypertens 2022, 31(4):339-343 View PDF

Dörr K, Kainz A, Oberbauer R.

84. Prediction models for living organ transplantation are poorly developed, reported and validated: a systematic review. J Clin Epidemiol. 2022, 145:126-135 View PDF

Haller MC, Aschauer C, Wallisch C, Leffondré K, van Smeden M, Oberbauer R, Heinze G

83. Viewpoint article: Organ transplants of the future: planning for innovations including xenotransplantation. Transplant Int 2021, 34(11):2006-2018 View PDF

Cozzi E, Schneeberger S, Bellini MI, Berglund E, Böhmig G, Fowler K, Hoogduijn M, Jochmans I, Marckmann G, Marson L, Neuberger J, Oberbauer R, Pierson RN 3rd, Reichart B, Scobie L, White C, Naesens M; ESOT Workstream 1 of the TLJ (Transplantation Learning Journey) project.

82. Renal Delivery of Pharmacologic Agents During Machine Perfusion to Prevent Ischaemia-Reperfusion Injury: From Murine Model to Clinical Trials. Front Immunol. 2021, 12:673562 View PDF

Franzin R, Stasi A, Fiorentino M, Simone S, Oberbauer R, Castellano G, Gesualdo L

81. Precision medicine in transplantation and hemodialysis. Nephrol Dial Transplant. 2021, 36(Supplement_2):31-36 View PDF

Oberbauer R, Meyer TW.
.

80. Optimization of tacrolimus in kidney transplantation: New pharmacokinetic perspectives. Transplant Rev (Orlando). 2020, 34(2):100531 View PDF

Oberbauer R, Bestard O, Furian L, Maggiore U, Pascual J, Rostaing L, Budde K.

79. COVID-19 and renal transplantation. Nephrologe 2021, 28:1-8.

Regele F, Oberbauer R.

78. Response to: “Biostatistics pitfalls: Lessons learned from analysis of medical data” by Yin et al. Contemp Clin Trials. 2020, 89:105916

Reindl-Schwaighofer R, Heinzel A, Heinze G, Kammer M, Oberbauer R

77. Pre-existing malignancies in renal transplant candidates-time to reconsider waiting times. 2019, 34(8):1292-1300. View PDF

Watschinger B, Budde K, Crespo M, Heemann U, Hilbrands L, Maggiore U, Mariat C, Oberbauer R, Oniscu GC, Peruzzi L, Sorensen SS, Viklicky O, Abramowicz D; ERA-EDTA DESCARTES Working Group.

76. Summary of the Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation. Transplantation. 2020, 104(4):708-714 View PDF

Chadban SJ, Ahn C, Axelrod DA, Foster BJ, Kasiske BL, Kher V, Kumar D, Oberbauer R, Pascual J, Pilmore HL, Rodrigue JR, Segev DL, Sheerin NS, Tinckam KJ, Wong G, Balk EM, Gordon CE, Earley A, Rofeberg V, Knoll GA

75. Deceased donor kidney allocation schemes and international exchange. Curr Opin Organ Transplant. 2020, 25(1):66-73 View PDF

Heemann U, Oberbauer R, Sprangers B, Gökalp C, Bemelman F; Eurotransplant Kidney Advisory Committee.

74. Novel insights into Non-HLA Alloimmunity in Kidney Transplantation. Transpl Int. 2020, 33:5-17 View PDF

Reindl-Schwaighofer R, Heinzel A, Gualdoni GA, Mesnard L, Claas FHJ, Oberbauer R.

73. To test or to estimate? P-values versus effect sizes. Transpl Int. 2020, 33(1):50-55 View PDF

Dunkler D, Haller M, Oberbauer R, Heinze G.

72. Histocompatibility: minor differences have a major impact. Nat Rev Nephrol. 2019, 15(9):529-530. View PDF

Reindl-Schwaighofer R, Oberbauer R.

71. How to increase kidney transplant activity throughout Europe-an advocacy review by the European Kidney Health Alliance. Nephrol Dial Transplant. 2019, 34(8):1254-1261 View PDF

Vanholder R, Stel VS, Jager KJ, Lameire N, Loud F, Oberbauer R, de Jong RW, Zoccali C.

70. Normal and pathologic erythropoiesis in adults: from gene regulation to targeted treatment concepts. Haematologica. 2018, 103(10):1593-1603 View PDF

Valent P, Büsche G, Theurl I, Uras IZ, Germing U, Stauder R, Sotlar K, Füreder W, Bettelheim P, Pfeilstöcker M, Oberbauer R, Sperr WR, Geissler K, Schwaller J, Moriggl R, Béné MC, Jäger U, Horny HP, Hermine O

69. Dialysis vintage and outcomes in renal transplantation. Nephrol Dial Transplant 2019, 34(4):555-560 View PDF

Haller M, Kammer M, Oberbauer R

68. Strategies for long-term preservation of kidney graft function. The Lancet 2017, 389: 2152–62 View PDF

Wekerle T, Segev D, Lechler R, Oberbauer R

67. Recent advances in kidney transplantation: a viewpoint from the Descartes advisory board. Nephrol Dial Transplant. 2018, 3(10):1699-1707 View PDF

Abramowicz D, Oberbauer R, Heemann U, Viklicky O, Peruzzi L, Mariat C, Crespo M, Budde K, Oniscu GC.

66. Optimizing hypertension management in renal transplantation: a call to action. Nephrol Dial Transplant 2017, 32(12):1959-1962 View PDF

Halimi JM, Persu A, Sarafidis PA, Burnier M, Abramowicz D, Sautenet B, Oberbauer R, Mallamaci F, London G, Rossignol P, Wuerzner G, Watschinger B, Zoccali C

65. An unjustified benefit: immortal time bias in the analysis of time-dependent events. Transpl Int. 2018, 31:125-130 View PDF

Gleiss A, Oberbauer R, Heinze G

64. Mechanisms underlying human genetic diversity: consequence for anti-graft antibody responses. Transpl Int 2018, 31(3):239-250 View PDF

Reindl-Schwaighofer R, Heinzel A, Signorini L, Thaunat O, Oberbauer R.

63. Immunological Consequences of Kidney Cell Death. Cell Death & Disease, 2018, 25;9(2):114. View PDF

Sarhan M, von Mässenhausen A, Hugo C, Oberbauer R, Linkermann A

62. Reducing the costs of chronic kidney disease while delivering quality health care: a call to action. Nat Rev Nephrol. 2017, 13(7):393-409 View PDF

Vanholder R, Annemans L, Brown E, Gansevoort R, Gout-Zwart JJ, Lameire N, Morton RL, Oberbauer R, Postma MJ, Tonelli M, Biesen WV, Zoccali C; European Kidney Health Alliance.

61. Criteria for and Appropriateness of Renal Transplantation in Elderly Patients With End-Stage Renal Disease: A Literature Review and Position Statement on Behalf of the European Renal Association-European Dialysis and Transplant Association Descartes Working Group and European Renal Best Practice. Transplantation 2016, 100(10):e55-65 View PDF

Segall L, Nistor I, Pascual J, Mucsi I, Guirado L, Higgins R, Van Laecke S, Oberbauer R, Van Biesen W, Abramowicz D, Gavrilovici C, Farrington K, Covic A

60. Combating costs of CKD while delivering high quality health care: a health economic call to action. Nature Reviews Nephrology 2017, 13(7):393-409

Vanholder R, Annemans L, Brown E, Gansevoort R, Gout-Zwart J, Lameire N, Morton R, Oberbauer R, Postma M, Tonelli M, Van Biesen W, Zoccali C

59. Editorial: Progression of Interstitial Fibrosis in Kidney Transplantation. CJASN 2016, 11(12):2110-2112 View PDF

Oberbauer R

58. Transplantation in Austria, Transplantation 2016, 100:1785-1787 View PDF

Berlakovich GA, Zuckermann A, Schneeberger S, Rosenkranz AR, Oberbauer R

57. Immunosuppression in the elderly renal allograft recipient: a systematic review. Transplant Rev 2016, 30(3):144-53

Montero N, Pérez-Sáez MJ, Pascual J, DESCARTES Working Group, DESCARTES ERA-EDTA Board, Abramowicz D, Budde K, Dudley C, Hazzan M, Klinger M, Maggiore U, Oberbauer R, Pascual J, Sorensen SS, Viklicky O

56. Does pre-emptive transplantation vs post start of dialysis transplantation with a kidney from a living donor improve outcomes after transplantation? A systematic literature review and position statement by the Descartes working group and ERBP. Nephrol Dial Transplant 2016,31(5):691-697 View PDF

Abramowicz D, Hazzan M, Maggiore U, Peruzzi L, Cochat P, Oberbauer R, Haller M, Van Biesen W for the Descartes working group and the European Renal Best Practice (ERBP) advisory board

55. Drugs meeting the molecular basis of diabetic kidney disease: bridging from molecular mechanism to personalized medicine. NDT 2015, 30 (suppl 4):iv105-iv112. View PDF

Lambers Heerspink HJ, Oberbauer R, Perco P, Heinzel A, Heinze G, Mayer G, Mayer B

54. Molecular disease presentation in diabetic nephropathy. NDT 2015, 30 (suppl 4):iv17-iv25. View PDF

Heinzel A, Mühlberger I, Stelzer G, Lancet D, Oberbauer R, Martin M, Perco P.

53. Prognostic clinical and molecular biomarkers of renal disease in type 2 diabetes. NDT 2015, 30 (suppl 4):iv86-iv95 View PDF

Pena MJ, de Zeeuw D, Mischak H, Jankowski J, Oberbauer R, Woloszczuk W, Benner J, Dallmann G, Mayer B, Mayer G, Rossing P, Lambers Heerspink HJ

52. Prediction of prevalence of chronic kidney disease in diabetic patients in countries of the European Union up to 2025. NDT 2015, 30 (suppl 4):iv113-iv118. (IF 4.8) View PDF

Kainz A, Hronsky M, Stel VS, Jager KJ, Geroldinger A, Dunkler D, Heinze G, Tripepi G, Oberbauer R

51. Population Attributable Fraction of Modifiable Lifestyle Factors for Chronic Kidney Disease and Mortality in Individuals with Diabetes. NDT Supp 2015 (in press)

Dunkler D, Kohl M, Mann, Teo, Yusuf, Oberbauer R

50. Genome-wide Studies to Identify Risk Factors for Kidney Disease with a Focus on Patients with Diabetes. NDT 2015, 30 (suppl 4):iv26-iv34 (IF 4.8) View PDF

Regele F, Jelencsics K, Shiffman D, Pare G, McQueen MJ, Mann JEF, Oberbauer R

49. microRNAs in Kidney Transplantation. Nephrol Dial Transplant 2015; 30(6):910-917. View PDF

Wilflingseder J, Reindl-Schwaighofer R, Sunzenauer J, Kainz A, Heinzel A, Mayer B, Oberbauer R

48. Strategies to increase the donor pool and access to kidney transplantation: an international perspective. Nephrol Dial Transplant. 2015 Feb;30(2):217-22 View PDF

Maggiore U, Oberbauer R, Pascual J, Viklicky O, Dudley C, Budde K, Schwartz Sorensen S, Hazzan M, Klinger M, Abramowicz D for the ERA-EDTA-DESCARTES working group

47. Regression methods for investigating risk factors of chronic kidney disease outcomes: the state of the art. BMC Nephrol. 2014 Mar 14;15(1):45 View PDF

Boucquemont J, Heinze G, Jager KJ, Oberbauer R, Leffondre K.

46. Health economics and European Renal Best Practice – is it time to bring health economics into evidence-based guideline production in Europe? Nephrol Dial Transplant. 2014 Nov;29(11):1994-7 View PDF

Haller MC, Vanholder R, Oberbauer R, Zoccali C, Van Biesen W.

45. Blood disorders after kidney transplantation. Transplant Rev (Orlando). 2014 Apr;28(2):63-75. View PDF

Reindl-Schwaighofer R, Oberbauer R.

44. Anemia and Erythrocytosis in patients after kidney transplantation. Transpl Int 2012, 25:1013-1023 View PDF

Malyszko J, Oberbauer R, Watschinger B.

43. Integrative Analysis of -Omics Data and Histologic Scoring in Renal Disease and Transplantation: Renal Histogenomics. Neph Sem 2010, 30:520-530 View PDF

Perco P, Oberbauer R.

42. Renal phosphate handling in human – what can we learn from hereditary hypophosphatemias? Europ J Clin Invest 2010, 40:552-560 View PDF

Amatschek S, Haller M, Oberbauer R.